US Patent Issued to TRx Biosciences on July 14 for "Compositions having improved bioavailability of therapeutics" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,502, issued on July 14, was assigned to TRx Biosciences Ltd. (London).

"Compositions having improved bioavailability of therapeutics" was invented by John Brew (St. Albans, Great Britain), Daniel Gooding (Cambridge, Great Britain) and Robin M. Bannister (Saffron Walden, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification discloses pharmaceutical composition disclosed herein comprises one or more therapeutic compounds, one or more glycerolipids, and one or more digestion enhancers. The disclosed glycerolipids comprise one or more hard fats and one or more liquid fats. The disclosed digestion enhancers comprise one o...